[1] |
Wang Yu,Ji QH,Huang CP,et al.Predictive factors for level VI lymph node metastasis in papillary thyroid microcarcinoma[J].Zhonghua Wai Ke Za Zhi,2008, 46(24):1899-901.[王宇, 嵇庆海,黄彩平,等. 甲状腺乳头状微癌Ⅵ区淋巴结转移相关因素分析[J]. 中华外科杂志, 2008, 46(24):1899-901.]
|
[2] |
Li XL,Gao M,Zhen XQ,et al.Clinical and biological characteristics of papillary thyroid microcarcinoma[J].Zhongguo Zhong Liu Lin Chuang,2008, 35(23):1325-7.[李小龙,高明,郑向前等. 甲状腺乳头状微小癌的临床生物学特性研究[J].中国肿瘤临床,2008,35(23):1325-7.]
|
[3] |
Gao M, Li XL,Gao SY,et al.The clinical biocharacteristics of different histopathological variants in patients of papillary thyroid carcinoma[J].Zhonghua Pu Tong Wai Ke Za Zhi,2006,21(8):588-90.[高明,李小龙,高松源,等. 甲状腺乳头状癌组织学变型的临床生物学特性[J].中华普通外科杂志,2006,21(8):588-90.]
|
[4] |
Beesley MF,McLaren KM.Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules [J].Histopathology,2002,41(3):236-43.
|
[5] |
Tong J,Wang Y,Da JP,et al. Usefulness of CK19,HBME-1and Galectin-3 expressions in differential diagnosis of thyroid papillary microcarcinoma from benign lesions[J].Zhonghua Zhong Liu Za Zhi, 2011, 33(8):599-604.[佟杰,王岩,笪冀平,等.CK19 HBME-1 Galectin-3 等表达在甲状腺乳头状微小癌与良性病变鉴别诊断中的意义[J].中华肿瘤杂志,2011, 33(8):599-604.]
|
[6] |
Sugitani I,Kasai N,Fujimoto Y,et al.A novel classification system for patients with PTC:addition of the new variables of large (3cm or greater) nodal metastases and reclassification during the follow-up period[J].Surgery,2004,135(2):139-48.
|
[7] |
Henry JF,Gramatica L,Denizot A,et al.Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma[J].Langerbecks Arch Surg,1998,383(2):167-9.
|
[8] |
Kim HY,Park WY,Lee KE, et al. Comparative analysis of gene expression profiles of papillary thyroid microcarcinoma and papillary carcinoma[J]. J Cancer Res Ther,2010,6(4):452-7.
|
[9] |
Lee J,Rhee Y,Lee S,et al.Frequent, aggressive behaviors of thyroid microcarcinoma in Korean patients[J].Endocr J,2006,53(5):627-32.
|
[10] |
Chow SM,Law SC,Chan JK,et al.Papillary microcarcinoma of the thyroid-prognostic signficance of lymph node metastasis and multifocality[J].Cancer,2003,98(1):31-40.
|
[11] |
Shao Y,Cai XJ,Gao L,et al. Clinical factors related to central compartment lymph node metastasis in papillary thyroid microcarcinoma:clinical analysis of 117 cases[J].Zhonghua Yi Xue Za Zhi,2009,89(6):403-5.[邵雁,蔡秀军,高力,等. 甲状腺微小乳头状癌中央区淋巴结转移及临床因素分析[J]. 中华医学杂志,2009,89(6):403-5.]
|
[12] |
Sun CZ,Chen FJ,Zeng ZY,et al.Treatment and prognosis of papillary thyroid microcarcinoma[J]. Zhonghua Pu Tong Wai Ke Za Zhi,2011,26 (4):283-5.[孙传政,陈福进,曾宗渊,等.甲状腺乳头状微小癌124例的治疗和预后分析[J]. 中华普通外科杂志,2011,26(4):283-5.]
|